Effect of maternal use of labetalol on the cerebral autoregulation in premature infants

Alexander Caicedo, Liesbeth Thewissen, Gunnar Naulaers, Petra Lemmers, Frank Van Bel, Sabine Van Huffel

Research output: Chapter in Book/Report/Conference proceedingConference contribution

9 Scopus citations

Abstract

Hypertensive disorders of pregnancy (HDP) are normally treated to avoid maternal complications. In this study we aimed to investigate if there was an effect of maternal HDP treatment on the cerebral autoregulation of the neonates by analysing measurements of mean arterial blood pressure (MABP) and rScO 2 by means of correlation, coherence, and transfer function analysis. We found that these infants presented higher values of transfer function gain, which indicates impaired cerebral autoregulation, with a decreasing trend towards normality. We hypothesised that this trend was due to a vasodilation effect of the maternal use of labetalol due to accumulation, which disappeared by the third day after birth. Therefore, we investigated the values of pulse pressure in order to find evidence for a vasodilatory effect. We found that lower values of pulse pressure were present in these infants when compared with a control population, which, together with increased transfer function gain values, suggests an effect of the drug on the cerebral autoregulation.

Original languageEnglish (US)
Title of host publicationOxygen Transport to Tissue XXXV
PublisherSpringer New York LLC
Pages105-111
Number of pages7
ISBN (Print)9781461472568
DOIs
StatePublished - 2013
Externally publishedYes

Publication series

NameAdvances in Experimental Medicine and Biology
Volume789
ISSN (Print)0065-2598

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Effect of maternal use of labetalol on the cerebral autoregulation in premature infants'. Together they form a unique fingerprint.

Cite this